Intravenous treatment adherence of patients with chronic inflammatory rheumatic diseases during the COVID-19 pandemic: experience of a single center

Intravenous treatment adherence of patients with chronic inflammatory rheumatic diseases during the COVID-19 pandemic: experience of a single center

Introduction: Patients with chronic inflammatory rheumatic diseases (CIRD) who receive intravenous therapy requiring hospitalization are likely to be more affected than those with receiving oral therapy during COVID-19 pandemic. We aimed to investigate the effect of the COVID-19 pandemic on adherenc...

Full description

Bibliographic Details
Main Authors: Konak Hatice Ecem, Armağan Berkan, Güven Serdar Can, Atalar Ebru, Karakaş Özlem, Esmer Serdar, Eksin Mehmet Akif, Polat Bünyamin, Apaydin Hakan, Gök Kevser, Doğan İsmail, Erden Abdulsamet, Maraş Yüksel, Küçükşahin Orhan, Omma Ahmet, Erten Şükran
Format: Article
Language:English
Published: Sciendo 2022-09-01
Series:Romanian Journal of Internal Medicine
Subjects:
coronavirus
infliximab
intravenous infusion
patient adherence
rheumatology
rituximab
Online Access:https://doi.org/10.2478/rjim-2022-0010

Internet

https://doi.org/10.2478/rjim-2022-0010

Similar Items